PsychedeLinks is a weekly digest of news, business, and culture in the psychedelics industry curated by members of Emerge Law Group’s groundbreaking Psychedelics Industry Group.
Oregon Psilocybin Services Act
Several Rural Oregon Counties Vote Against Therapeutic Use of Psilocybin
Voters across Oregon mostly voted against allowing the therapeutic use of the psychedelic drug psilocybin on Tuesday.
Legalization, Decriminalization, & Other State Efforts
Colorado Voters Approve Psychedelics Legalization Ballot Initiative
Colorado voters approved an initiative on the ballot to legalize possession of certain psychedelics and create psilocybin “healing centers” on Tuesday. More than four years after Denver became the first U.S. city to decriminalize so-called magic mushrooms, setting off a national reform movement, the…
Research, Therapy, & Science
How Psychedelics Can Transform End-of-Life Care
Psilocybin is on the ballot in Colorado this year—and the results could be transformative for people facing death.
What Promise Do Psychedelics Hold As Therapeutics?
When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for depression, PTSD, anxi…
Psychedelics Can Treat PTSD, So Should They Be Given to Soldiers?
Welcome to the Dose, my weekly dispatch on the psychedelics and cannabis industries. At last week’s Wonderland Miami conference, panelists discussed psychedelics’ role in everything from trauma to sexuality and life extension. One topic in particular is at the heart of a decades-old controversy arou…
NIH-Funded Psychedelic Trial Will Study Whether Hallucinogens Can Help Smokers Quit
Early research has found that psilocybin, the psychedelic compound found in “magic mushrooms,” helped smokers kick the habit.
Business
Insider’s Peek At Mammoth Of Psychedelics VCs, Palo Santo’s Investment Fundamentals & Specificities
(Part one of a four-part series) Daniel Goldberg and Tim Schlidt are co-founders and partners behind Palo Santo, one of the most remarkable VC funds investing in psychedelics today. The company recently closed a capital round of $50 million for investment in a diverse portfolio of psychedelic medici…
Sublingual Psychedelics Startup Nets $60M for Depression Trials
Investors are betting sublingual drug delivery can unlock the potential of a psychedelic,
Culture
Archaeologists Find a Trove of Ancient Human Sacrifices Fed Psychedelic Plants Before Death
In analysis of mummified heads and cadavers discovered on the Southern coast of Peru has pushed back the earliest known date of psychedelic cactus use and other psychoactive plants. Toxicology reports on five individuals who were ritually executed between 500 to 2100 years ago revealed the use of coca leaves (which contain cocaine), hallucinogenic San Pedro cactus and Banisteriopsis caapi, a plant often used in the psychedelic brew ayahuasca.
Subscribe
Subscribe to PsychedeLinks to receive essential weekly articles on news, business, and culture in the psychedelics industry, delivered straight to your inbox.
